A new CSIRO report titled "AI Trends for Healthcare" reveals how AI is now embedded in real-world clinical settings for more connected, safer and more efficient health care.
Jun 29, 2026
0
5
A drug from the same family licensed for use in patients with Duchenne muscular dystrophy and blood cancer could transform the treatment of meningioma—the most common form of primary brain tumor in adults. Scientists at the ...
Jun 29, 2026
0
4
A team of experimental oncology researchers at the University of Alberta is shedding light on how the deadly brain cancer glioblastoma spreads. In newly published research, they identify a potential treatment target to slow ...
Jun 6, 2026
0
14
Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival ...
Jun 2, 2026
0
27
For the first time, researchers have used machine learning—a type of artificial intelligence (AI)—to identify the most important drivers of cancer survival in nearly all the countries in the world.
Jan 13, 2026
0
50
A single, targeted high dose of radiation delivered before other treatments could completely eradicate tumors in most women with early-stage, operable hormone-positive breast cancer, according to a study led by UT Southwestern ...
Nov 17, 2025
0
120
Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says one more factor should be considered—chronological age.
Nov 10, 2025
0
23
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new Phase III randomized trial.
Sep 29, 2025
0
13
University of Kentucky Markey Cancer Center researcher Weisi Yan, M.D., Ph.D., recently shared his work on radiation therapy at a major international conference, showcasing how new techniques could better protect patients' ...
Jul 14, 2025
0
13
Targeted cancer drugs known as CDK4/6 inhibitors have improved outcomes for patients with advanced or metastatic HR+/HER2- breast cancer, but many patients still eventually relapse and become resistant to therapy. New research ...
Jul 7, 2025
0
21
